The EsophyX transoral fundoplication, known as the TIF procedure, is an endoscopic, incisionless method for remodeling and augmentation of the anti-reflux barrier valve.
Dr. Starpoli and Lenox Hill Hospital have been designated a select site for the an important study registry to learn more about the benefits of the EsophyX TIF procedure for reflux disease.
The EsophyX® TIF procedure enables the surgeon to simply and safely reconstruct the antireflux barrier and gastroesophageal flap valve, resulting in the effective elimination of GERD. The majority of patients have an excellent response and no longer require taking daily medicines.
No incisions are required and the procedure is performed through the mouth (transoral) under endoscopic visualization. Patients are able to return to normal activities within a few days following the procedure.
In early clinical studies, 85% of patients remained off daily PPIs (proton pump inhibitors) and 75% experienced a total elimination of heartburn at one year after the EsophyX TIF procedure. In view of concerns of over the long-term effects of PPI therapy, the TIF procedure is a viable alternative to daily medical therapy.
In cases with a larger hiatal hernia, a laparoscopic repair of the hiatal hernia is necessary and can be combined with the TIF procedure. In this case, the TIF would serve to provide the needed fundoplication that must be performed following the repair of a hiatal hernia so to enhance the antireflux valve at the endo of the esophagus. The TIF is then an alternative to a standard laparoscopic fundplication. The combination of the laparoscopic hernia repair and the EsophyX TIF procedure is referred to as a "hybrid" procedure.
